Literature DB >> 20558635

Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing.

H Christina Fan1, Yair J Blumenfeld, Usha Chitkara, Louanne Hudgins, Stephen R Quake.   

Abstract

BACKGROUND: Noninvasive prenatal diagnosis with cell-free DNA in maternal plasma is challenging because only a small portion of the DNA sample is derived from the fetus. A few previous studies provided size-range estimates of maternal and fetal DNA, but direct measurement of the size distributions is difficult because of the small quantity of cell-free DNA.
METHODS: We used high-throughput paired-end sequencing to directly measure the size distributions of maternal and fetal DNA in cell-free maternal plasma collected from 3 typical diploid and 4 aneuploid male pregnancies. As a control, restriction fragments of lambda DNA were also sequenced.
RESULTS: Cell-free DNA had a dominant peak at approximately 162 bp and a minor peak at approximately 340 bp. Chromosome Y sequences were rarely longer than 250 bp but were present in sizes of <150 bp at a larger proportion compared with the rest of the sequences. Selective analysis of the shortest fragments generally increased the fetal DNA fraction but did not necessarily increase the sensitivity of aneuploidy detection, owing to the reduction in the number of DNA molecules being counted. Restriction fragments of lambda DNA with sizes between 60 bp and 120 bp were preferentially sequenced, indicating that the shotgun sequencing work flow introduced a bias toward shorter fragments.
CONCLUSIONS: Our results confirm that fetal DNA is shorter than maternal DNA. The enrichment of fetal DNA by size selection, however, may not provide a dramatic increase in sensitivity for assays that rely on length measurement in situ because of a trade-off between the fetal DNA fraction and the number of molecules being counted.

Mesh:

Substances:

Year:  2010        PMID: 20558635     DOI: 10.1373/clinchem.2010.144188

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  66 in total

Review 1.  From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.

Authors:  Diana W Bianchi
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  An SNP panel for the analysis of paternally inherited alleles in maternal plasma using ion Torrent PGM.

Authors:  Donggui Yang; Hao Liang; Shaobin Lin; Qing Li; Xiaoyan Ma; Jun Gao; Hongyu Sun; Qingqing Chen; Jianzhu Wu; Xueling Ou
Journal:  Int J Legal Med       Date:  2017-04-20       Impact factor: 2.686

3.  Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.

Authors:  Stephanie C Y Yu; K C Allen Chan; Yama W L Zheng; Peiyong Jiang; Gary J W Liao; Hao Sun; Ranjit Akolekar; Tak Y Leung; Attie T J I Go; John M G van Vugt; Ryoko Minekawa; Cees B M Oudejans; Kypros H Nicolaides; Rossa W K Chiu; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 4.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

5.  Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma.

Authors:  John A Tynan; Payam Mahboubi; Lesley L Cagasan; Dirk van den Boom; Mathias Ehrich; Paul Oeth
Journal:  J Mol Diagn       Date:  2011-05-06       Impact factor: 5.568

Review 6.  Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer.

Authors:  Kay T Yeung; Soham More; Brian Woodward; Victor Velculescu; Hatim Husain
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 7.  Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.

Authors:  Mary Beth Terry; Jasmine A McDonald; Hui Chen Wu; Sybil Eng; Regina M Santella
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 8.  Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

Authors:  Daniel A Haber; Victor E Velculescu
Journal:  Cancer Discov       Date:  2014-05-06       Impact factor: 39.397

9.  Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma.

Authors:  Anupama Srinivasan; Diana W Bianchi; Hui Huang; Amy J Sehnert; Richard P Rava
Journal:  Am J Hum Genet       Date:  2013-01-10       Impact factor: 11.025

Review 10.  Circulating tumor DNA in colorectal cancer: opportunities and challenges.

Authors:  Feifei Bi; Qiwei Wang; Qian Dong; Yuanhe Wang; Liqun Zhang; Jingdong Zhang
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.